The antimicrobial activity of thyme essential oil against multidrug resistant clinical bacterial strains

Microbial Drug Resistance

Volumn 18, Issue 2, 2012, Pages 137-148

  Sienkiewicz, Monika ^a   Łysakowska, Monika ^a   Denys, Paweł ^a   Kowalczyk, Edward ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; ESSENTIAL OIL; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; NITROFURANTOIN; NORFLOXACIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; THYME ESSENTIAL OIL; THYME OIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ABDOMINAL INFECTION; AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; DISK DIFFUSION; ENTEROCOCCUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; MOUTH INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; THYME; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA; HUMANS; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; PLANT OILS; PSEUDOMONAS; STAPHYLOCOCCUS; THYMUS PLANT;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ESCHERICHIA; PSEUDOMONAS; STAPHYLOCOCCUS; THYMUS VULGARIS;

EID: 84859612261     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2011.0080     Document Type: Article

References (58)

1. Adams, R.P. 2007. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy, 4th edition. Allured Publishing Corporation, Carol Stream, IL.
2. Arpin, C., C. Quentin, F. Grobost, E. Cambau, J. Robert, V. Dubois, L. Coulange, and C. André. 2009. Nationwide survey of extended-spectrum {beta}-lactamaseproducing Enterobacteriaceae in the French community setting. J. Antimicrob. Chemother. 63:1205-1214.
3. Averbeck, D., and S. Averbeck. 1998. DNA photodamage, repair, gene induction and enotoxicity following exposures to 254nm UV and 8-methoxypsoralen plus UVA in a eukaryotic cell system. Photochem. Photobiol. 68:289-295. (Pubitemid 128472711)
4. Bekhechi, C., F.A. Bekkara, D.E. Abdelouahid, F. Tomi, and J. Casanova. 2007. Composition and antibacterial activity of the essential oil of Thymus fotanesii Boiss. et Reut. from Algeria. J. Essent. Oil Res. 19:594-596. (Pubitemid 350252930)
5. Ben Salah, M., M. Abderraba, M.R. Tarhouni, and H. Abdelmelek. 2009. Effects of ultraviolet radiation on the kinetics of in vitro percutaneous absorption of lavender oil. Int. J. Pharm. 382:33-38.
6. Bender, E.A., A.L.P. Freitas, K.C. Reiter, L. Lutz, and A.L. Barth. 2009. Identification, antimicrobial resistance and genotypic characterization of Enterococcus spp. isolated in Porto Alegre. Brazil. Braz. J. Microbiol. 40:693-700.
7. Bousmaha-Marroki, L., F. Atik-Bekkara, F. Tomi, and J. Casanova. 2007. Chemical composition and antibacterial activity of the essential oil of Thymus ciliatus (Desf.) Benth. ssp. eu-ciliatus Maire from Algeria. J. Essent. Oil Res. 19: 490-493. (Pubitemid 47436799)
8. Butt, T., M. Usman, R.N. Ahmad, and I. Saif. 2005. Emergence of metallo-beta-lactamase producing Pseudomonas aeruginosa in Pakistan. J. Pak. Med. Assoc. 55:302-304. (Pubitemid 41787453)
9. [CLSI] Clinical and Laboratory Standard Institute. 2009. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement. CLSI Document M100-S19. Clinical and Laboratory Standard Institute, Wayne, PA.
10. Conceição, N., C. de Oliveira Cda, P.R. da Silva, B.G. Avila, and A.G. de Oliveira. Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: A 4-year study. 2011 Rev. Soc. Bras. Med. Trop. 44:177-181.
11. Courvalin, P. 2005. Genetics of glycopeptides resistance in Gram-positive pathogens. Int. J. Med. Microbiol. 249: 479-486. (Pubitemid 40249688)
12. Dal Sasso, M. 2006. Thymol: Inhibitory activity on Escheichia coli and Stphylococcus aureus adhesion to human vaginal cells. J. Essent. Oil. Res. 18:455-461. (Pubitemid 44106135)
13. De, A.S., S.H. Kumar, and S.M. Baveja. 2010. Prevalence of metallo-b-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Indian J. Crit. Care Med. 14:217-219.
14. De Feo, V., M. Bruno, B. Tahiri, F. Napolitano, and F. Senatore. 2003. Chemical composition and antibacterial activity of essential oils from Thymus spinulosus Ten. (Lamiaceae). J. Agric. Food. Chem. 51:3849-3853.
15. Deotale, V., D.K. Mendiratta, U. Raut, and P. Narang. 2010. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Indian J. Med. Microbiol. 28:24-26.
16. Dijoux, N., Y. Guingand, C. Bourgeois, S. Durand, C. Fromageot, C. Combe, and P.J. Ferret. 2006. Assessment of the phototoxic hazard of some essential oils using modified 3T3 neutral red uptake assay. Toxicol. In Vitro 20:480-489.
17. Edris, A.E. 2007. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytother. Res. 21:308-323. (Pubitemid 46603595)
18. European Pharmacopoeia. 2008. 6th edition. Council of Europe, Strasbourg.
19. Fabio, A., C. Cermelli, G. Fabio, P. Nicoletti, and P. Quaglio. 2007. Screening of the antibacterial effects of a variety of essential oils on microorganisms responsible for respiratory infections. Phytother. Res. 21:374-377. (Pubitemid 46595984)
20. Foucault, M.L., P. Courvalin, and C. Grillot-Courvalin. 2009. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:2354-2359.
21. Friedman, C.R., and C.G. Whitney. 2008. It's time for a change in practice: Reducing antibiotic use can alter antibiotic resistance. J. Infect. Dis. 197:1082-1083. (Pubitemid 351590041)
22. Gagliotti, C., A Balode, F. Baquero, J. Degener, H. Grundmann, D. Guör, V. Jarlier, G. Kahlmeter, J. Monen, D.L. Monnet, G.M. Rossolini, C. Suetens, K. Weist, and O. Heuer. 2011. EARS-Net Participants (Disease Specific Contact Points for AMR). Escherichia coli and Staphylococcus aureus: Bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARSNet, formerly EARSS), 2002 to 2009. Euro Surveill. 16:pii: 19819.
23. Gales, A.C, H.S. Sader, J. Ribeiro, C. Zoccoli, A. Barth, and A.C. Pignatari. 2009. Antimicrobial susceptibility of grampositive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008). Braz. J. Infect. Dis. 13:90-98.
24. Gholam Reza, T., and M. Mohammad Hadi. 2007. Antibacterial activity and chemical constituents of essential oils of Thymus persicus and Thymus eriocalyx from west of Iran. Pakistan J. Biol. Sci. 10:3923-3926.
25. Giordani, R., P. Regli, J. Kaloustian, and H. Portugal. 2006. Potentation of antifungal activity of amphoteracin B by essential oil from Cinnamonium cassia. Phytother. Res. 20: 58-61. (Pubitemid 43171589)
26. Guba, R. 2001. Toxicity myths-essential oils and their carcinogenic potential. Int. J. Aromather. 11:76-83.
27. Gulluce, M., M. Sokmen, D. Daferera, G. Agar, H. Ozkan, N. Kartal, M. Polissiou, A. Sokmen, and F. Sahin. 2003. In vitro antibacterial, antifungal, and antioxidant activities of the essential oil and methanol extracts of herbal parts and callus cultures of Satureja hortensis L. J. Agric. Food Chem. 51:3958-3965.
28. Hajhashemi, V., A. Ghannadi, and B. Sharif. 2003. Antiinflammatory and analgesic properties of the leaf extracts and essential oil of Lavandula angustifolia Mill. J. Ethnopharmacol. 89:67-71. (Pubitemid 37163801)
29. Hazzit, M., A. Baaliouamer, M.L. Faleiro, and M.G. Miguel. 2006. Composition of the essential oils of Thymus and Origanum species from Algeria and their antioxidant and antimicrobial activities. J. Agric. Food Chem. 54:6314-6321. (Pubitemid 44375791)
30. Howe, R.A., N.M. Brown, and R.C. Spencer. 1996. The new threats of Gram positive pathogens: Re-emergence of things past. J. Clin. Pathol. 49:444-449. (Pubitemid 26226530)
31. Joulain, D., and W.A. Koönig. 1998. The Atlas of Spectral Data of Sesquiterpene Hydrocarbons. E.B.-Verlag, Hamburg.
32. Kachadourian, R., and B.J. Day. 2006. Flavonoid-induced glutathionedepletion: Potential implications for cancer treatment. Free Radic. Biol. Med. 41:65-76. (Pubitemid 43866451)
33. Kalemba, D., and A. Kunicka. 2003. Antibacterial and antifungal properties of essential oils. Curr. Med. Chem. 10:813-829. (Pubitemid 36443237)
34. Lis-Balchin, M., S. Deans, and S. Hart. 2007. Bioactive Geranium oils from different commercial sources. J. Essent. Oil Res. 8:281-290.
35. Livermore, D.M., R. Canton, M. Gniadkowski, P. Nordmann, G.M. Rossolini, G. Arlet, J. Ayala, T.M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: Changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. (Pubitemid 47072053)
36. Manosroi, J., P. Dhumtanom, and A. Manosroi. 2006. Antiproliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett. 235:114-120.
37. Nguyen, L.H., D.I. Hsu, V. Ganapathy, K. Shriner, and A. Wong-Beringer. 2008. Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome. J. Antimicrob. Chemother. 61:714-720. (Pubitemid 351321151)
38. Ohkawara, S., T. Tanaka-Kagawa, Y. Furukawa, T. Nishimura, and H. Jinno. 2010. Activation of the human transient receptor potential vanilloid subtype 1 by essential oils. Biol. Pharm. Bull. 33:1434-1437.
39. Perry, N.S., C. Bollen, E.K. Perry, and C. Ballard. 2003. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol. Biochem. Behav. 75:651-659. (Pubitemid 36936899)
40. Polish Pharmacopeia VIII. 2008. 8th edition. Polish Pharmaceutical Society, Warsaw.
41. Prabhu, K, S. Rao, and V. Rao. 2011. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J. Lab. Physicians 3:25-27.
42. Price, A., and L. Price. 1999. Aromatherapy for Health Professionals, 3rd edition. Churchill Livingstone, London.
43. Rosato, A., C. Vitali, N. De Laurentis, D. Armenise, and M. Antonietta Milillo. 2007. Antibacterial effect of some essential oils administered alone or in combination with norfloxacin. Phytomedicine 14:727-732. (Pubitemid 47539098)
44. Rosooli, I., and S. Mirmostafa. 2003. Bacterial susceptibility to and chemical composition of essential oils from Thymus kotschyanus and Thymus persicus. J. Agr. Food Chem. 51:2200-2205.
45. Sader, H.S., and R.N. Jones. 2009. Antimicrobial susceptibility of gram-positive bacteria isolated from US medical centers: Results of the daptomycin surveillance program (2007-2008). Diagn. Microbiol. Infect. Dis. 65:158-162.
46. Sader, H.S., R.N. Jones, A.C. Gales, J.B. Silva, and A.C. Pignatari. 2004. SENTRY antimicrobial surveillance program report: Latin American and Brazilian result for 1997 through 2001. Braz. J. Infect. Dis. 8:25-79.
47. Schmitt, S., U. Schaefer, F. Sporer, and J. Reichling. 2010. Comparative study on the in vitro human skin permeation of monoterpenes and phenylpropanoids applied in rose oil and in form of neat single compounds. Die Pharm. 65:102-105.
48. Schmitt, S., U.F. Schaefer, L. Doebler, and J. Reichling. 2009. Cooperative interaction of monoterpenes and phenylpropanoids on the in vitro human skin permeation of complex composed essential oils. Planta Med. 75:1381-1385.
49. Shin, S., and J. Kim. 2005 In vitro inhibitory activities of essential oils from two Korean Thymus species against antibiotic-resistant pathogens. Arch. Pharm. Res. 28:897-901. (Pubitemid 43086179)
50. Sylvestre, M., A. Pichette, A. Longtin, F. Nagau, and J. Legault. 2006. Essential oil analysis and anticancer activity of leaf essential oil of Croton flavens L. from Guadeloupe. J. Ethnopharmacol. 103:99-102. (Pubitemid 41681147)
51. Tsuneki, H., E.L. Ma, S. Kobayashi, N. Sekizaki, K. Maekawa, T. Sasaoka, M.W. Wang, and I. Kimura. 2005. Antiangiogenic activity of beta-eudesmol in vitro and in vivo. Eur. J. Pharmacol. 512:105-115. (Pubitemid 40544343)
52. Vercesi, A.E., A.J. Kowaltowski, M.T. Grijalba, A.R. Meinicke, and R.F. Castilho. 1997. The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 17:43-52. (Pubitemid 27267591)
53. Walsh, T.R., M.A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-beta-lactamases: The quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
54. Werner, G., T.M. Coque, A.M. Hammerum, R. Hope, W. Hryniewicz, A. Johnson, I. Klare, K.G. Kristinsson, R. Leclercq, C.H. Lester, M. Lillie, C. Novais, B. Olsson-Liljequist, L.V. Peixe, E. Sadowy, G.S. Simonsen, J. Top, J. Vuopio-Varkila, R.J. Willems, W. Witte, and N. Woodford. 2008. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13:pii. 19046.
55. Wimmerstedt, A., and G. Kahlmeler. 2008. Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumonia and Streptococcus pyogenes. Clin. Microbiol. Infect. 14:315-321. (Pubitemid 351356521)
56. Wu, X.J., T. Stahl, Y. Hu, F. Kassie, and V. Mersch-Sundermann. 2006. The production of reactive oxygen species and the mitochondrial membrane potential are modulated during onion oil-induced cell cycle arrest and apoptosis in A549 cells. J. Nutr. 136:608-613. (Pubitemid 43363743)
57. Xu, Z., L. Li, M.E. Shirtliff, B.M. Peters, B. Li, Y. Peng, M.J. Alam, S. Yamasaki, and L. Shi. 2011. Resistance class 1 integron in clinical methicillin-resistant Staphylococcus aureus strains in southern China, 2001-2006. Clin. Microbiol. Infect. 17:714-718.
58. Zhou, S., H.L. Koh, Y. Gao, Z.Y. Gong, and E.J. Lee. 2004. Herbal bioactivation: The good, the bad and the ugly. Life Sci. 74:935-968. (Pubitemid 37522131)